In contrast, mouse studies showed that MUC1 deficiency effectively mitigated tumor development and metastasis [11,12], and downregulation of MUC1 expression also promoted the pro-apoptotic activity of genotoxic agents on mammary tumor cells [8]. This evidence concerns the gene MUC1 and breast cancer.